Stockholm, Sweden 16th of August 2011

 

Xbrane Bioscience develops innovative tools for efficient production of proteins. Based on requests from costumers and users, Xbrane Bioscience now offers Xbrane Rhamex System™ based vectors with a kanamycin resistance marker.

 
These vectors are very suitable for efficient large-scale production of proteins. Xbrane Rhamex System™ is tightly controlled and the expression intensity can be extremely well controlled to enable high expression yields, even of toxic and otherwise challenging proteins. The system is compatible with E. coli and other Gram-negative bacteria.

 

For more information, contact:
Lykke Abdon, Director of Marketing
Xbrane Bioscience AB   
Phone: +46 73 938 58 60 
E-mail: lykke@xbrane.com

 

About Xbrane Bioscience
Xbrane Bioscience develops and commercializes platforms for the efficient and cost-effective production of proteins and vaccines. The company was founded early 2008, as a spin-off company from the world-leading Center for Biomembrane Research at the Department of Biochemistry & Biophysics of Stockholm University, Sweden. The company has developed and sells two bacterial based protein expression systems providing unprecedented versatility, Xbrane Lemo System™ and Xbrane Rhamex System™. Xbrane Bioscience is currently further expanding its portfolio of innovative technologies, including platforms for the development of multivalent vaccines and the efficient production of toxic and unstable proteins. For more information about Xbrane Bioscience visit www.xbrane.com.

 

_________________________________________________________________________